Prof. Rubino’s research showed that the anti-diabetes effect of certain bariatric procedures, particularly gastric bypass surgery, results from mechanisms beyond weight loss. This evidence provided a scientific rationale for surgical treatment of type 2 diabetes, including that of less obese patients. His research-finding and theories also point to the role of the gastrointestinal tract in the pathophysiology of diabetes and obesity. His clinical expertise includes laparoscopic, bariatric, metabolic, and upper digestive surgery, including gastric bypass, sleeve gastrectomy, gastric banding, and novel procedures. He is internationally recognized as one of the world’s leaders in the research, teaching, and practice of metabolic and weight-loss surgery.

‍
Professor Rubino received his MD and completed his residency in general surgery at the Catholic University / Policlinico Gemelli in Rome, Italy. He completed fellowships in laparoscopic surgery at the European Institute of Telesurgery in Strasbourg, France; Mount Sinai Medical Center, New York; and Cleveland Clinic. A member of many professional organizations, Professor Rubino is the recipient of numerous awards, has given hundreds of presentations throughout the world, and is the author of over 100 articles in peer-reviewed journals and book chapters.